PMC 5431260
The term Ozempic Face describes facial hollowing or sagging that can appear after rapid weight loss with medications such as Ozempic (semaglutide), Wegovy, or Zepbound
Ipamorelins selective stimulation of growth hormone release combined with MK 677s broader impact on growth hormone and IGF-1 pathways can lead to more pronounced physiological effects in experimental models
Retatrutide is what scientists call a "triple agonist" because it activates three hormone receptors simultaneously: GLP-1, GIP, and glucagon
Local fishing families are a crucial (my words, and they feel right) but endangered species

Primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin secretion increases when blood glucose is elevated but not when glucose levels are normal or low, reducing hypoglycemia risk Suppressed glucagon secretion : These medications inhibit glucagon release from pancreatic alpha cells, decreasing hepatic glucose production Delayed gastric emptying : GLP-1 receptor activation slows the rate at which food leaves the stomach, moderating postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the brain, particularly in areas controlling satiety and food reward, are activated, leading to reduced appetite and caloric intake These combined effects result in improved glycemic control in patients with type 2 diabetes and significant weight loss in both diabetic and non-diabetic individuals